Centaurus (JNJ5467414SMM2001): A Randomized Phase II Trial to Evaluate Three Daratumumab (DARA) Dose Schedules in Smoldering Multiple Myeloma (SMM)

Journal article

Peer reviewed

C.C Hofmeister, H Goldschmidt, M Qi, R Bandekar, H Amin, T Ahmadi, O Landgren and Carl Ola Landgren

Clinical lymphoma, myeloma and leukemia, Vol.15, pp.e175-e175

2015-09

Metrics

3 Record Views

Title: Centaurus (JNJ5467414SMM2001): A Randomized Phase II Trial to Evaluate Three Daratumumab (DARA) Dose Schedules in Smoldering Multiple Myeloma (SMM)
Creators: C.C Hofmeister - The Ohio State University
H Goldschmidt - University Hospital Heidelberg
M Qi - Janssen
R Bandekar - Janssen
H Amin - Janssen
T Ahmadi - Janssen
O Landgren - Memorial Sloan Kettering Cancer Center
Carl Ola Landgren - Miller School of Medicine
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.15, pp.e175-e175
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031713449102976